This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Asthma and allergy (more control exclusions)
ASTHMA_ALLERG_EXMORE
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions
ALLERG_ASTHMA
Check pre-conditions, main-only, mode, registry filters None
0 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints
-
Remove individuals based on genotype QC
5206
ASTHMA_ALLERG_EXMORE
Control definitions
Control exclude
J10_ASTHMA, ALLERG_ASTHMA, VOCALCORDDYS, I9_HEARTFAIL, J10_HYPERSPNEUMONI, ASTHMA_EXCL
Control conditions
not ALLERG_ASTHMA
Extra metadata
First used in FinnGen datafreeze
DF2
No upset plot: script not run.
No upset table: script not run.
Similar endpoints
↥List of similar endpoints to
Asthma and allergy (more control exclusions)
based on the number of shared cases.
Broader endpoints:
- Asthma and allergy
- Allergic asthma (mode) (more control exclusions)
- Allergic asthma (mode)
- Asthma (diagnoses ohter than nonallergic)
- Asthma
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5206 | 3725 | 1481 |
| Unadjusted prevalence (%) | 1.26 | 1.62 | 0.81 |
| Mean age at first event (years) | 27.02 | 27.81 | 25.03 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: ASTHMA_ALLERG_EXMORE – Asthma and allergy (more control exclusions)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Asthma and allergy (more control exclusions)
↥Endpoint not on priority list, no data to show.